News-Medical.Net November 4, 2024
Hebrew University of Jerusalem

Breast cancer is the most common malignancy among Western women, with up to 10% of cases attributed to genetic variants. Despite this, the roots of many familial cases remain unexplored, largely due to the complex nature of the genetic factors involved. Addressing this critical gap, a recent study led by Prof. Dina Schneidman-Duhovny from the Rachel and Selim Benin School of Computer Science and Engineering at the Hebrew University of Jerusalem has provided new insights into the genetic underpinnings of familial breast cancer, especially prevalent in families of Middle Eastern descent.

The study utilizes an innovative analysis method tailored for examining genetic variations in families with a history of breast cancer. This method combines cutting-edge machine learning with detailed analysis...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Patient / Consumer, Provider, Survey / Study, Trends
Optimizing Health System Pharmacies: Leveraging Data, Performance Indicators, and Automation
Open-source AI model can assess biomedical images and text to provide real-time, patient-focused insight
NHS pilots iPhone app to rule out throat cancer
Physicians, hospitals decry 2025 Medicare payment rates
AI-Assisted Colonoscopy Linked to Increased Benign Lesion Removal

Share This Article